The hot flashes and night sweats that plague breast cancer survivors during years-long hormone-suppressing therapy are eased ...

Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4 ...

The study, published Tuesday in The Lancet Oncology, focused on women under 55 with and without a uterus. CBS News medical ...

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology. Katie M. O ...

A groundbreaking study by the National Institutes of Health (NIH) is shifting the conversation around hormone therapy and ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

Dr. Alicia Arnold and Dr. Priyanka Raval discuss first- and later-line treatment options for those with ER-positive, ...

Women using a certain type of hormone therapy to treat menopause symptoms could be at higher risk for breast cancer, according to a new study. The study, published Tuesday in The Lancet Oncology ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

Hormone therapy may be used by young women to relieve symptoms from hormone-­related conditions, menopause, or gynecologic surgery. Long-term use of estrogen/progestin hormone therapy was positively ...

Hormone therapy for metastatic prostate cancer can improve quality of life and longevity for those receiving treatment.